237 related articles for article (PubMed ID: 18371532)
1. Socioeconomic status and the incidence of ESRD.
Ward MM
Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
Ward MM
Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
Ward MM; Studenski S
Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
[TBL] [Abstract][Full Text] [Related]
4. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
[TBL] [Abstract][Full Text] [Related]
5. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors.
Perneger TV; Whelton PK; Klag MJ
Arch Intern Med; 1995 Jun; 155(11):1201-8. PubMed ID: 7763126
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
[TBL] [Abstract][Full Text] [Related]
7. Are large nonfunctional kidneys risk factors for posttransplantation urinary tract infection in patients with end-stage renal disease due to autosomal dominant polycystic kidney disease?
Salehipour M; Jalaeian H; Salahi H; Bahador A; Davari HR; Nikeghbalian S; Sagheb MM; Raiss-Jalali GA; Roozbeh J; Behzadi S; Janghorban P; Sepas HN; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):887-8. PubMed ID: 17524840
[TBL] [Abstract][Full Text] [Related]
8. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
[TBL] [Abstract][Full Text] [Related]
9. Family history of end-stage renal disease among hemodialyzed patients in Poland.
Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
[TBL] [Abstract][Full Text] [Related]
10. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis.
Ward MM
J Rheumatol; 2007 Oct; 34(10):2024-7. PubMed ID: 17696272
[TBL] [Abstract][Full Text] [Related]
11. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
[TBL] [Abstract][Full Text] [Related]
12. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of childhood and adult socioeconomic status and incidence of type 2 diabetes in women.
Lidfeldt J; Li TY; Hu FB; Manson JE; Kawachi I
Am J Epidemiol; 2007 Apr; 165(8):882-9. PubMed ID: 17284723
[TBL] [Abstract][Full Text] [Related]
14. Exploring the pathways between socioeconomic status and ESRD.
Merkin SS
Am J Kidney Dis; 2008 Apr; 51(4):539-41. PubMed ID: 18371527
[No Abstract] [Full Text] [Related]
15. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
Alam A; Perrone RD
Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
[TBL] [Abstract][Full Text] [Related]
16. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
Kitiyakara C; Eggers P; Kopp JB
Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
[TBL] [Abstract][Full Text] [Related]
17. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
[TBL] [Abstract][Full Text] [Related]
18. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.
Lai MN; Lai JN; Chen PC; Hsieh SC; Hu FC; Wang JD
Am J Kidney Dis; 2010 Mar; 55(3):507-18. PubMed ID: 20116155
[TBL] [Abstract][Full Text] [Related]
19. Concomitant nephrectomy of massively enlarged kidneys and renal transplantation in autosomal dominant polycystic kidney disease.
Tabibi A; Simforoosh N; Abadpour P; Gholamrezaie HR; Nafar M
Transplant Proc; 2005 Sep; 37(7):2939-40. PubMed ID: 16213267
[TBL] [Abstract][Full Text] [Related]
20. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
Stewart JH; McCredie MR; Williams SM; McDonald SP
Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
